These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

857 related articles for article (PubMed ID: 9841098)

  • 1. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
    Rochefort H
    C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and clinical significance of cathepsin D in breast cancer metastasis.
    Garcia M; Platet N; Liaudet E; Laurent V; Derocq D; Brouillet JP; Rochefort H
    Stem Cells; 1996 Nov; 14(6):642-50. PubMed ID: 8948022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor mediated inhibition of cancer cell invasion and motility: an overview.
    Rochefort H; Platet N; Hayashido Y; Derocq D; Lucas A; Cunat S; Garcia M
    J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):163-8. PubMed ID: 9699869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Estrogen-induced genes in breast cancer, and their medical importance].
    Rochefort H
    Bull Acad Natl Med; 1999; 183(5):955-68; discussion 968-71. PubMed ID: 10465000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells.
    Briozzo P; Morisset M; Capony F; Rougeot C; Rochefort H
    Cancer Res; 1988 Jul; 48(13):3688-92. PubMed ID: 3378211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of the overexpression of the cathepsin D gene in breast cancer and consequences in the metastatic process].
    Rochefort H
    C R Seances Soc Biol Fil; 1991; 185(6):415-21. PubMed ID: 1822391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of hyaluronidase expression, invasiveness and tubule formation promotion in ER (-) and ER (+) breast cancer cell lines in vitro.
    Wang XY; Tan JX; Vasse M; Delpech B; Ren GS
    Chin Med J (Engl); 2009 Jun; 122(11):1300-4. PubMed ID: 19567141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Angiogenic effect of interleukin-8 in breast cancer and its association with estrogen receptor].
    Lin Y; Wang SM; Huang RP
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1419-23. PubMed ID: 16029657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells.
    Glondu M; Liaudet-Coopman E; Derocq D; Platet N; Rochefort H; Garcia M
    Oncogene; 2002 Aug; 21(33):5127-34. PubMed ID: 12140763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin-D and c-erb-B 2 have an additive prognostic value for breast cancer patients.
    Scorilas A; Yotis J; Gouriotis D; Keramopoulos A; Ampela K; Trangas T; Talieri M
    Anticancer Res; 1993; 13(5C):1895-900. PubMed ID: 7903524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ; Raney S
    Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.
    Thompson EW; Paik S; Brünner N; Sommers CL; Zugmaier G; Clarke R; Shima TB; Torri J; Donahue S; Lippman ME
    J Cell Physiol; 1992 Mar; 150(3):534-44. PubMed ID: 1537883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells.
    Glondu M; Coopman P; Laurent-Matha V; Garcia M; Rochefort H; Liaudet-Coopman E
    Oncogene; 2001 Oct; 20(47):6920-9. PubMed ID: 11687971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins.
    Sumida T; Itahana Y; Hamakawa H; Desprez PY
    Cancer Res; 2004 Nov; 64(21):7886-92. PubMed ID: 15520195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of interleukin-8 in the progression of estrogen receptor-negative breast cancer.
    Yao C; Lin Y; Ye CS; Bi J; Zhu YF; Wang SM
    Chin Med J (Engl); 2007 Oct; 120(20):1766-72. PubMed ID: 18028768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
    Reddel RR; Sutherland RL
    Cancer Res; 1987 Oct; 47(20):5323-9. PubMed ID: 3652038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogens and epithelial ovarian cancer.
    Cunat S; Hoffmann P; Pujol P
    Gynecol Oncol; 2004 Jul; 94(1):25-32. PubMed ID: 15262115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1alpha/CXCL12.
    Kishimoto H; Wang Z; Bhat-Nakshatri P; Chang D; Clarke R; Nakshatri H
    Carcinogenesis; 2005 Oct; 26(10):1706-15. PubMed ID: 15917309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.